NPC Intracellular Cholesterol Transporter 2

Alternative Names

  • NPC2
  • NPC2 Gene
  • Epididymal Secretory Protein
  • HE1
Back to search Result
OMIM Number

601015

NCBI Gene ID

10577

Uniprot ID

P61916

Length

13,578 bases

No. of Exons

4

No. of isoforms

2

Protein Name

NPC intracellular cholesterol transporter 2

Molecular Mass

16570 Da

Amino Acid Count

151

Genomic Location

chr14:74,479,935-74,493,512

Gene Map Locus
14q24.3

Description

This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. [From RefSeq]

Molecular Genetics

The NPC2 gene ranges from base pair 74,016,395 to base pair 74,029,836 on chromosome 14q24.3 giving a size of 13,441 bases. The normal gene has five exons and a single transcript of 0.9 kb in all tissues. Recent studies have identified about 13 mutations of the NPC2 gene responsible for causing NPC disease.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_006432.5:c.88G>ASaudi ArabiaNC_000014.9:g.74486431C>TBenign, Likely BenignLikely PathogenicNiemann-Pick Disease, Type C2NG_007117.1:g.11951G>A; NM_006432.5:c.88G>A; NP_006423.1:p.Val30Met151220873183281

Other Reports

Algeria

In 2001, Millat et al. studied the genotype/phenotype correlations in two patients from different Algerian families with NPC2. Fibroblast strains were used in the study and diagnosis of NPC had been assessed by filipin staining and by measurement of LDL- induced cholesteryl-ester formation. Molecular analysis revealed the presence of a nonsense homozygous mutation, E20X (glu20 to ter), in one patient and a splice mutation, IVS2+5G-A, in the other (a female alive at age 21 years). Homozygosity of the E20X mutation was associated with a severe rapid disease course; pronounced lung involvement leading to death from respiratory failure. On the other hand, the splice mutation was confirmed to be in a homozygous state by sequencing the genomic DNA of both consanguineous parents. The female patient with the IVS2+5G-A mutation was found to have splenomegaly at age 6.5 years, school problems, epileptic fits beginning at age 11 years, mental retardation, and slow progression, but was still able to walk normally at age 21 years. Remarkably an affected sister with a similar course was still alive at age 27 years. In two independent experiments, the electrophoretic profile of RT-PCR products from RNA isolated from the patient with splice mutation showed multiple bands. RT-PCR products therefore were subcloned, and 32 subclones were analyzed by sequencing. The analysis revealed 30 abnormally spliced cDNAs and two normally spliced cDNAs. Among the 30 mutant cDNAs, only three classes were observed- cDNA with a deletion of the last 76 bp of exon 2 and cDNA with a 10-bp insertion between exons 2 and 3.

© CAGS 2024. All rights reserved.